GLIOBLASTOMA
Glioblastoma Multiforme (GBM) is an aggressive primary brain tumor known for its complex pathogenesis and rapid progression. It is a grade 4 CNS tumor, which is the most aggressive form of diffuse gliomas. A grade 4 tumor has rapid growth, invasion into surrounding brain tissue, and poor prognosis. This educational overview explores its molecular development, invasive patterns, and critical diagnostic considerations for clinical assessment.
Learning Outcomes
-
Describe what glioblastoma is and explain why it is classified as a malignant tumor.
-
Explain how glioblastoma develops and spreads within the brain.
-
Identify key genetic mutations and molecular pathways involved in glioblastoma.
-
Describe the standard treatment approach (surgery, radiation, chemotherapy).
Key Terms and Definitions
-
Tumor (neoplasm): abnormal mass from uncontrolled cell division
-
Benign: slow-growing, non-invasive
-
Malignant: cancerous, invasive
-
Glioblastoma: Highly malignant often from astrocytes, may also arise from neural stem/progenitor cells
-
Hallmarks: Rapid proliferation, Extensive necrosis, Abnormal blood vessel formation (angiogenesis)
-
Molecular drivers: genetic mutations in cell growth, survival, and DNA repair pathways
Curriculum Overview
Let’s Get Started
Explore the fundamental pillars of Glioblastoma scholarship. Each module below provides a structured summary of the clinical path from diagnosis to patient support.
Understanding the molecular origins of GBM, focusing on the accumulation of genetic mutations in astrocytes and the influence of environmental factors.
An analysis of how malignant cells infiltrate healthy brain parenchyma through perineural invasion and microvascular co-option.